Concord Healthcare Group Co., Ltd. (HKG: 2453)
Hong Kong
· Delayed Price · Currency is HKD 15.92
+0.02 (0.13%)
Nov 15, 2024, 11:57 AM HKT
Concord Healthcare Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 472.46 | 538.65 | 472.17 | 470.51 | 166.32 |
| Revenue Growth (YoY) | -22.99% | 14.08% | 0.35% | 182.89% | - |
| Cost of Revenue | 537.08 | 603.71 | 614.77 | 517.62 | 158.43 |
| Gross Profit | -64.62 | -65.06 | -142.6 | -47.11 | 7.89 |
| Selling, General & Admin | 237.13 | 252.97 | 274 | 305.56 | 258.54 |
| Research & Development | 32.05 | 36.44 | 41.32 | 40.38 | 11.27 |
| Other Operating Expenses | -2.09 | -2.81 | -7.76 | 47 | 23.9 |
| Operating Expenses | 281.26 | 295.51 | 327.2 | 392.93 | 293.72 |
| Operating Income | -345.88 | -360.57 | -469.8 | -440.05 | -285.83 |
| Interest Expense | -106.84 | -108.01 | -274.48 | -435.31 | -323.47 |
| Interest & Investment Income | 3.7 | 7.28 | 7.79 | 5.47 | 5.99 |
| Earnings From Equity Investments | -1.31 | -1.74 | -0.22 | -0.16 | -0.07 |
| Currency Exchange Gain (Loss) | -1.31 | -0.04 | -0.64 | 0.56 | 1.65 |
| Other Non Operating Income (Expenses) | 28.39 | 30.57 | 41.68 | - | - |
| EBT Excluding Unusual Items | -423.25 | -432.49 | -695.67 | -869.49 | -601.73 |
| Gain (Loss) on Sale of Assets | 41.01 | - | -1.13 | 29.89 | 1.63 |
| Asset Writedown | -0.37 | -0.25 | -0.77 | - | - |
| Other Unusual Items | -38.67 | 0.14 | 50.4 | 3.27 | 2.29 |
| Pretax Income | -418.73 | -432.59 | -647.17 | -836.34 | -597.81 |
| Income Tax Expense | -4.57 | -6.2 | -9.95 | -5.2 | -6.47 |
| Earnings From Continuing Operations | -414.16 | -426.39 | -637.22 | -831.13 | -591.34 |
| Minority Interest in Earnings | 53.47 | 53.3 | 95.82 | 14.54 | 8.08 |
| Net Income | -360.69 | -373.09 | -541.4 | -816.59 | -583.26 |
| Net Income to Common | -360.69 | -373.09 | -541.4 | -816.59 | -583.26 |
| Shares Outstanding (Basic) | 696 | 665 | 479 | - | - |
| Shares Outstanding (Diluted) | 696 | 665 | 479 | - | - |
| Shares Change (YoY) | 6.68% | 38.63% | - | - | - |
| EPS (Basic) | -0.52 | -0.56 | -1.13 | - | - |
| EPS (Diluted) | -0.52 | -0.56 | -1.13 | - | - |
| Free Cash Flow | -189.13 | 23.92 | -175.67 | -325.96 | -694.04 |
| Free Cash Flow Per Share | -0.27 | 0.04 | -0.37 | - | - |
| Gross Margin | -13.68% | -12.08% | -30.20% | -10.01% | 4.75% |
| Operating Margin | -73.21% | -66.94% | -99.50% | -93.53% | -171.85% |
| Profit Margin | -76.34% | -69.26% | -114.66% | -173.56% | -350.68% |
| Free Cash Flow Margin | -40.03% | 4.44% | -37.20% | -69.28% | -417.29% |
| EBITDA | -231.87 | -244.99 | -355.52 | -356.26 | -229.19 |
| EBITDA Margin | -49.08% | -45.48% | -75.29% | -75.72% | -137.80% |
| D&A For EBITDA | 114.01 | 115.58 | 114.29 | 83.79 | 56.64 |
| EBIT | -345.88 | -360.57 | -469.8 | -440.05 | -285.83 |
| EBIT Margin | -73.21% | -66.94% | -99.50% | -93.53% | -171.85% |
Source: S&P Capital IQ. Standard template. Financial Sources.